bupivacaine has been researched along with Chronic Progressive External Ophthalmoplegia in 1 studies
Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, RM | 1 |
| Griffiths, PG | 1 |
| Chinnery, PF | 1 |
| Turnbull, DM | 1 |
1 other study available for bupivacaine and Chronic Progressive External Ophthalmoplegia
| Article | Year |
|---|---|
Evaluation of bupivacaine-induced muscle regeneration in the treatment of ptosis in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome.
Topics: Adult; Blepharoptosis; Bupivacaine; Evaluation Studies as Topic; Follow-Up Studies; Humans; Kearns-S | 1999 |